Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ron James

Orthopaedic Surgery Sacramento, CA Medical Doctor

NPI 1437237104 CMS profile 20255

3160 Folsom Blvd, Sacramento, CA 95816

Open in the dashboard

General payments

$41,629

167 records reported · program years 2019–2025

Research payments

$4,200

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ron James of Sacramento, CA is reported in the CMS Open Payments database as having received $41,629 across 167 general payments and $4,200 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $606 13
2024 General $8,882 40
2024 Research $4,200 2
2023 General $1,027 13
2022 General $3,074 18
2021 General $6,843 45
2020 General $1,549 8
2019 General $19,647 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ron James
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Ron James were reported at $606. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Ron James Orthopaedic Surgery median Middle half National median
2019 $19,647 $644 $140–$2,844 $163
2020 $1,549 $312 $75–$1,860 $114
2021 $6,843 $520 $117–$2,495 $132
2022 $3,074 $598 $128–$2,731 $149
2023 $1,027 $461 $128–$2,264 $160
2024 $8,882 $497 $134–$2,475 $164
2025 $606 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Lima USA, Inc. $18,385 10 payments
  2. Smith+Nephew, Inc. $7,775 58 payments
  3. Maxx Orthopedics, Inc. $4,311 10 payments
  4. Conformis, Inc. $3,497 24 payments
  5. Stryker Corporation $3,155 24 payments
  6. restor3d, inc. $2,008 10 payments
  7. NextStep Arthropedix, LLC $344 1 payment
  8. International Life Sciences $338 2 payments
  9. Ortho Development Corporation $321 5 payments
  10. Orthalign Inc $271 2 payments
  11. Other $1,226 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $28,197 45 payments
  2. Food and Beverage $12,231 121 payments
  3. Consulting Fee $1,200 1 payment
Products named General payments · program years 2019–2025
  1. Master SL $17,939 6 payments
  2. H-Max $17,939 6 payments
  3. REAL INTELLIGENCE $2,824 23 payments
  4. iTotal Identity CR $2,785 17 payments
  5. CORI $1,956 11 payments
  6. MAKO Knees, Hips $1,347 6 payments
  7. Delta TT Cups $1,200 1 payment
  8. JOURNEY II $1,189 7 payments
  9. MAKO Knees, Hips $1,187 8 payments
  10. POLAR3 $1,080 3 payments
  11. Other $8,734 105 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Maxx Orthopedics, Inc. $4,200 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

517

Median for Orthopedic Surgery: 203

Drug cost

$8,356

Median for Orthopedic Surgery: $1,433

Branded share of claims

38.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 135 $5,604
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 172 $1,479
Gabapentin Generic 107 $959
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 26 $182
Amoxicillin Generic 40 $51
Ondansetron Hcl Generic 13 $42
Meloxicam Generic 24 $39

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$125,764

Of which drugs: $1,125

Medicare patients

324

Average age 72

Services billed

2,656

199 women, 125 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 34%
Depression 26%
Chronic kidney disease 22%
Ischemic heart disease 19%
COPD 17%
Atrial fibrillation 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 105 893 $685

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

169 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record